FFO
NVO

Fortitude Family Office’s Novo Nordisk NVO Stock Holding History

Fortitude Family Office’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-612
Closed -$34K – 2060
2025
Q3 		$34K Sell
612
-226
-27% -$13.2K 0.01% 295
2025
Q2 		$57.8K Buy
838
+34
+4% +$2.31K 0.02% 226
2025
Q1 		$55.8K Buy
804
+490
+156% +$40.5K 0.02% 208
2024
Q4 		$27K Hold
314
– – 0.01% 384
2024
Q3 		$37.4K Hold
314
– – 0.01% 290
2024
Q2 		$44.8K Hold
314
– – 0.03% 188
2024
Q1 		$40.3K Hold
314
– – 0.03% 180
2023
Q4 		$32.5K Buy
+314
New +$31.1K 0.02% 225

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fortitude Family Office's NVO Position: Q4 2025 in Review

Fortitude Family Office sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 612 shares — an estimated $34K sold.

Fortitude Family Office first reported a position in NVO in Q4 2023 and held it in 8 quarters. The position peaked at $57.8K in Q2 2025. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • Fortitude Family Office reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • Fortitude Family Office sold 612 Novo Nordisk shares in Q4 2025, an estimated $34K.
  • Fortitude Family Office first reported a position in Novo Nordisk in Q4 2023 and held it in 8 quarters.
  • Fortitude Family Office's Novo Nordisk position peaked at $57.8K in Q2 2025.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on Fortitude Family Office's 13F filing for Q4 2025, filed 15 Jan 2026.